Naïve T cells from WAS patients consistently fail to upregulate the activation markers CD69 and CD25, proliferate, or secrete interleukin (IL)-2, interferon (IFN)-γ, and tumor necrosis factor in response to TCR/CD28-mediated activation (8–11). The gene discussed is IL2; the disease is Wiskott-Aldrich syndrome.